Development of Biosensor-type-DNA Chip for the Diagnosis of Cancer

开发用于癌症诊断的生物传感器型DNA芯片

基本信息

  • 批准号:
    11794017
  • 负责人:
  • 金额:
    $ 9.6万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for University and Society Collaboration
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2001
  • 项目状态:
    已结题

项目摘要

Development of a biosensor-type-DNA chip for the diagnosis of cancer is an objective of this research. To attain this objective, two lines of research projects were designed.For the first line of the project, we systematically examined expression profiles in the liver with various diseases including hepatocellular carcinoma. Over one hundred clinical materials were analyzed with home-made DNA chips, and the expression profile in each disease was demonstrated. This study revealed that a DNA chip analysis gives new information that cannot be obtained by routine biochemical and pathological examinations, and made the DNA chip be a new diagnostic technique, or a new tumor marker. Using serial analysis of gene expression (SAGE), over 300,000 expressed tags in the liver were obtained and deposited into databases. A DNA chip, which predicts the efficacy of drugs against chronic hepatitis C, was put on the market.Another line of the project is to make a biosensor-type-DNA chip, which can be used in routine clinical settings on site. Using microelectrodes on a chip, target nucleic acids can be measured in liquid (applied for a patent in 2001). A small-size thermal cycler for the introduction of measurement on microelectrodes was developed (applied for a patent in 2000). A DNA spotter on a microelectrode was also developed (pending for a patent). Using these successive developments, a biosensor-type-DNA chip, which is small-size, less expensive compared with former laser-detection-type DNA chips, and faster for the clinical diagnosis, was made.
本研究的目的之一是开发一种用于癌症诊断的生物传感器型DNA芯片。为了实现这一目标,我们设计了两条研究路线,第一条路线是系统地检测包括肝细胞癌在内的各种疾病肝脏中的表达谱。用自制的DNA芯片分析了100多份临床资料,并展示了每种疾病的表达谱。本研究揭示了DNA芯片分析提供了常规生化和病理检查无法获得的新信息,使DNA芯片成为一种新的诊断技术,或一种新的肿瘤标志物。使用基因表达系列分析(SAGE),获得了肝脏中超过300,000个表达的标签并存入数据库。该项目的另一条线是制作生物传感器型DNA芯片,可用于现场常规临床设置。使用芯片上的微电极,可以在液体中测量目标核酸(2001年申请专利)。开发了用于引入微电极测量的小型热循环仪(2000年申请专利)。还开发了微电极上的DNA点样器(正在申请专利)。利用这些连续的发展,生物传感器型DNA芯片,这是小尺寸,比以前的激光检测型DNA芯片更便宜,更快的临床诊断,被制成。

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Masao Honda, et al.: "cDNA microarray analysis reveals differential gene expression between chronic hepatitis B and C hepatic lesions."Gastroenterology. (in press).
Masao Honda 等人:“cDNA 微阵列分析揭示了慢性乙型肝炎和丙型肝炎肝脏病变之间的基因表达差异。”胃肠病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tamiya Eiichi: "Biosensor-chip"BME. 15. 8-16 (2001)
田宫英一:“生物传感器芯片”BME。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Eishiro Mizukoshi: "Serum level of soluble interferon alpha/beta receptor as an inhibitory factor of IFN in the patients with chronic hepatitis C"Hepatology. 30. 1325-1331 (1999)
Eishiro Mizukoshi:“慢性丙型肝炎患者中作为干扰素抑制因子的可溶性干扰素α/β受体的血清水平”肝病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Taro Yamashita: "Comprehensive gene expression profile of a normal human liver"Biochemical and Biophysical Research Communications. 269. 110-116 (2000)
山下太郎:“正常人类肝脏的综合基因表达谱”生物化学和生物物理研究通讯。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masao Honda: "Differential Gene Expression Between Chronic Hepatitis B and C Hepatic Lesion"Gastroenterology. 120・4. 955-966 (2001)
本田正夫:“慢性乙型肝炎和丙型肝炎肝损伤之间的差异基因表达”胃肠病学120・4(2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KANEKO Shuichi其他文献

KANEKO Shuichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KANEKO Shuichi', 18)}}的其他基金

Study of the liver as an endocrine organ
肝脏作为内分泌器官的研究
  • 批准号:
    26253046
  • 财政年份:
    2014
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Liver producing hormones and life style related diseases
肝脏产生激素和生活方式相关疾病
  • 批准号:
    23249042
  • 财政年份:
    2011
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
A fundamental study of diplomatic documents from 8th to 10th century in East Asia
8至10世纪东亚外交文献基础研究
  • 批准号:
    23520875
  • 财政年份:
    2011
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Disturbance of hepatic function and over nutrition-related diseases
肝功能障碍和过度营养相关疾病
  • 批准号:
    18109008
  • 财政年份:
    2006
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Establishment of Genomics Based Hepatology
基于基因组学的肝病学建立
  • 批准号:
    13854015
  • 财政年份:
    2001
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Removal of Hepatitis C Virus in the Serum of Chimpanzees by Phasmapheresis
采血法去除黑猩猩血清中的丙型肝炎病毒
  • 批准号:
    10557054
  • 财政年份:
    1998
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Establishment of Gene Therapy for Advanced Hepatocellular Carcinoma with Intra- and Extra- Hepatic Metastases
晚期肝细胞癌肝内、肝外转移基因治疗的建立
  • 批准号:
    10470132
  • 财政年份:
    1998
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Gene Therapy for Advanced Hepatocellular Carcinoma using Transcriptional Control
使用转录控制治疗晚期肝细胞癌的基因疗法
  • 批准号:
    08670571
  • 财政年份:
    1996
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

中国北方人群肺癌患者Cancer/Testis抗原表达谱绘制表位鉴定及功能性抗原特异性CTL制备研究
  • 批准号:
    81673007
  • 批准年份:
    2016
  • 资助金额:
    54.0 万元
  • 项目类别:
    面上项目

相似海外基金

SpyTCR-RBNP - Engineering a highly targeted and biocompatible drug delivery system for solid cancer treatment
SpyTCR-RBNP - 设计用于实体癌症治疗的高度针对性和生物相容性的药物输送系统
  • 批准号:
    10095606
  • 财政年份:
    2024
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Collaborative R&D
e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families - a PanEuropean project supported by PanCare and Harmonic consortia
电子医疗工具可促进儿童到成年癌症患者、幸存者及其家人的生活质量平等 - 这是由 PanCare 和 Harmonic 联盟支持的 PanEuropean 项目
  • 批准号:
    10098114
  • 财政年份:
    2024
  • 资助金额:
    $ 9.6万
  • 项目类别:
    EU-Funded
Novel chelators for Scandium-44 in PET imaging of prostate cancer
用于前列腺癌 PET 成像的新型 Scandium-44 螯合剂
  • 批准号:
    2904564
  • 财政年份:
    2024
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Studentship
Intelligent Breast Cancer DiagnOsis and MonItoring Therapeutic Response Training Network (CanDoIt)
智能乳腺癌诊断和监测治疗反应训练网络(CanDoIt)
  • 批准号:
    EP/Y03693X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Research Grant
Development of the initial prototype of a pill sensor to detect colonic polyps and early bowel cancer
开发用于检测结肠息肉和早期肠癌的药丸传感器的初始原型
  • 批准号:
    MR/Y503411/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Research Grant
Investigation on naphthylisoquinoline alkaloids as potential antiausterity chemotherapy for pancreatic cancer
萘基异喹啉生物碱作为胰腺癌潜在抗紧缩化疗的研究
  • 批准号:
    23K26797
  • 财政年份:
    2024
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Investigate the feasibility of altering cancer drug sensitivity through modulation of AHR activity
研究通过调节 AHR 活性改变癌症药物敏感性的可行性
  • 批准号:
    24K10327
  • 财政年份:
    2024
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
I-Corps: Translation potential of using machine learning to predict oxaliplatin chemotherapy benefit in early colon cancer
I-Corps:利用机器学习预测奥沙利铂化疗对早期结肠癌疗效的转化潜力
  • 批准号:
    2425300
  • 财政年份:
    2024
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Standard Grant
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
  • 批准号:
    10481965
  • 财政年份:
    2024
  • 资助金额:
    $ 9.6万
  • 项目类别:
Proton radiation therapy combined with immunotherapy for enhancing antitumor immune responses in pancreatic cancer murine models.
质子放射治疗与免疫治疗相结合,增强胰腺癌小鼠模型的抗肿瘤免疫反应。
  • 批准号:
    24K10423
  • 财政年份:
    2024
  • 资助金额:
    $ 9.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了